2 March 2026 - Australians living with auto-immune disease, lymphoma, Parkinson's, motor neuron disease and cerebral palsy will have access to new medicines thanks to expanded and new listings on the PBS.

Ravulizumab (Ultomiris) will be listed for the first time for the treatment of newly diagnosed and treatment resistant patients with generalised myasthenia gravis who are anti‑acetylcholine receptor antibody positive.

Read Minister for Health press release